ACICLOVIR TABS/CAPS 200 MG

وزارة الصحة

Published: Sep 15, 2026

Updated: Sep 16, 2026

Source: joneps_jo

About This Opportunity

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Hospitals and Pharmaceuticals. Located in Jordan, Middle East & North Africa, this opportunity is open to firms and consortiums. Proposals must be submitted before September 21, 2026.

Published through JONEPS Jordan, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, sourced from Jordan via joneps_jo, is for the procurement of Aciclovir Tablets/Capsules 200 mg. This represents a standard pharmaceutical supply tender, likely managed by a governmental health entity, hospital procurement department, or a national pharmaceutical distributor. Aciclovir is an antiviral medication used to treat infections caused by herpes viruses, including genital herpes, cold sores, and shingles. The tender specifies the supply of 200 mg dosage in either tablet or capsule form. Essential requirements for bidders include strict adherence to pharmaceutical quality standards, such as Good Manufacturing Practices (GMP), and the provision of comprehensive product documentation. This typically involves detailed specifications for the active pharmaceutical ingredient (API) and the finished dosage form, certificates of analysis for supplied batches, and evidence of product stability. Packaging must be suitable for pharmaceutical products, ensuring protection and compliance with Jordanian labeling regulations. Suppliers are expected to possess valid manufacturing licenses and relevant regulatory approvals for their products. The tender will evaluate proposals based on the quality and compliance of the offered medication, the supplier's capacity and reliability, and competitive pricing, ensuring access to essential antiviral treatments.

Data provenance

This notice is sourced from JONEPS Jordan and was originally published on September 15, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About وزارة الصحة

وزارة الصحة has issued 2,104 procurement notices on BidsFactory, including 67 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for Jordan. Notices are distributed via JONEPS Jordan. Most recent publication: September 14, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit JONEPS Jordan to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is September 21, 2026. You have 5 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by وزارة الصحة in Jordan. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Jordan. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.